Boston assesses neurostimulator for migraine
This article was originally published in Clinica
Executive Summary
Eyeing the migraine market, Boston Scientific is to begin a pivotal US trial to test whether its implantable neurostimulator for treating pain in the legs and back might also provide relief for patients suffering from the agonising headaches.